Condition
Neurological Impairment
Total Trials
6
Recruiting
0
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 3 (1)
Trial Status
Completed5
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05739357Not ApplicableCompleted
Neurocognitive Function After Carotid Thrombendarterectomy
NCT02936219Active Not Recruiting
The PREWEAN Study. Weaning of Preterm Infants During the First Year of Life.
NCT00276380Phase 3Completed
A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke
NCT01456884Not ApplicableCompletedPrimary
Music Therapy for Pain Modification in Pediatric Palliative Care
NCT01847183Phase 2Completed
Evaluation of an School-based Alcohol Prevention Program for Middle School Students
NCT00917124Not ApplicableCompleted
Cerebral Oximetry and Neurocognitive Functions in Cardiosurgical Patients
Showing all 6 trials